First stone Bio-Incubator in Ghent

The Flemish biotech sector is growing fast, resulting in a clear demand for more infrastructure.

Ghent, 29 April 2022 - The Flemish biotech sector is growing fast. This expansion requires additional infrastructure. That is why VIB – in partnership with PMV and with financial support from the European Regional Development Fund (ERDF) – is building an ultramodern bio-incubator on 'Eiland Zwijnaarde', the new technology campus of Tech Lane Ghent Science Park. The first stone of the VIB Bio-Incubator was placed in the presence of Flemish Minister of Economy and Innovation Hilde Crevits.

The VIB Bio-Incubator will provide state-of-the-art lab infrastructure for up to 15 emerging biotech companies in the biopharmaceutical and agro-biotech fields. It will also be the new base for VIB headquarters. The building, designed by Modulo Architects and Stéphane Beel Architects in collaboration with the engineering firms Istema and Establis, is realized by a temporary partnership Jansen-Cordeel-Farbicom. It will be available by late 2023.

The new VIB Bio-Incubator is located strategically in the heart of the Ghent biotech ecosystem and close to VIB and UGent knowledge centers active in biotechnology.

Pioneering role in the bio-incubator ecosystem

VIB was one of the first parties to realize this important project of the growing Flemish biotech sector on the new technology campus. In the meantime, several other biotech players have specific plans to settle there, which means the science park will provide a new work location for more than three thousand employees. ​

Wim Goemaere (COO VIB): “A vibrant biotech sector and the need for infrastructure go hand in hand. VIB has taken up its responsibility to provide an answer to this, ever since the construction of our first Bio-Incubator in the late 1990s. Today, Flanders has a high-performance ecosystem of bio-incubators and accelerators. VIB will continue to focus on this and we will continue to play our pioneering role. The new VIB Bio-incubator is a perfect illustration of this."
Flemish Minister of Economy and Innovation Hilde Crevits: “Flanders is among the world’s leaders in biotech. Not only in terms of health, but also for sustainable food production. With the new Bio-Incubator of VIB and PMV we want to safeguard and strengthen this top position. We invest 4 million euros via European funding to provide even more lab space for young researchers or start-ups. The Bio-Incubator will bustle with creativity and innovation as a place where researchers and entrepreneurs can work on developments improving the health and prosperity of tomorrow.” ​ 

Investing in infrastructure

The realization of such a project requires specific expertise and the mobilization of many financial resources. The Flemish investment company PMV, also an important financier of (starting) biotech companies, has supported this project from the start, which is located at Tech Lane Ghent Science Park, a science park that PMV is realizing together with UGent and the City of Ghent. The park accommodates university spin-offs, start-ups and growing companies, and research centers of large international companies that have to fertilize each other and create new initiatives. PMV set up a project company with VIB to realize and operate the VIB Bio-Incubator. PMV coordinated the procedures and provided both capital and a subordinated loan to the project company.

Michel Casselman, CEO of PMV: " As financier and project director of the new building, we want to ensure the anchoring of the biotech cluster in Ghent. PMV is one of the most active investors in Belgium, with a portfolio of around 10% in life sciences. Not infrequently, these are companies that originated here in Ghent and that, thanks to PMV financing, can successfully develop into companies that work on today's major social challenges with new therapeutics, new diagnostics, sustainable agricultural applications, or food innovation. A steadfast partner like PMV is crucial for the success of such start-ups and their further development in our region.”

More info on the VIB Bio-incubator

Conceived as a vertical screen with two parts, the new VIB Bio-Incubator will have a dynamic and (inter)active side alongside the E40 and a creative side looking out over the campus. It also acts as an acoustic screen and protects the campus from the motorway. Together with a BREEAM certification and carbon-neutral operations, the building represents another great step in VIB's commitment to sustainable progress.

The VIB Bio-Incubator will offer up to 6,000 m² of net operational space, separated into flexible modules. Each module will have equipped lab areas, offices, support space, and storage space. To promote interaction between the companies on each floor there are informal meeting corners and flexible workplaces.

Visit the VIB Bio-Incubator website

Joran Lauwers

Joran Lauwers

Press Contact, VIB

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be